Physician profile
Ram Challapalli
NPI 1154313815
$17,512.74
in general payments reported to CMS, 2019-2025
40 companies · $5,557 in 2025
The $5,557 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,981 · 2020: $1,073 · 2021: $704 · 2022: $2,823 · 2023: $1,050 · 2024: $3,324 · 2025: $5,557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,990 · Travel and Lodging: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,990.44 |
| Travel and Lodging | $940.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $4,401.64 | 2019-2025 | Carto 3, Visitag Surpoint External Processing Unit, Qdot Micro Catheter |
| Biotronik INC. | $3,709.24 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Boston Scientific Corporation | $2,848.29 | 2021-2025 | Watchman Flx, Farapulse, Rhythmia Mapping System |
| Abbott Laboratories | $1,330.73 | 2024-2025 | Aveir, Jot Dx, Perclose Prostyle |
| Novartis Pharmaceuticals Corporation | $927.57 | 2019-2025 | |
| Medical Device Business Services, INC. | $745.02 | 2019 | |
| Medtronic, INC. | $673.29 | 2021-2025 | Micra, Reveal Linq, Linq II |
| Atricure, INC. | $558.12 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Janssen Pharmaceuticals, INC | $277.13 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $229.35 | 2019-2025 | |
| Amgen INC. | $203.66 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $169.19 | 2019-2025 | |
| Lexicon Pharmaceuticals, INC. | $141.06 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $138.58 | 2020-2025 | Sapien 3 Ultra Resilia |
| Amarin Pharma, INC. | $129.41 | 2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ram Challapalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.